Abstract
Background
Moyamoya syndrome is characterised by an occlusion of the carotid terminations with the development of collateral vessels. Our objective is to describe a series of infants presenting early-onset moyamoya-like syndrome, which may constitute a distinct entity.
Methods
From a cohort of children with rare cerebral vascular pathologies, we studied eight infants (28 days–1 year) with early-onset moyamoya-like syndrome demonstrated by angiography. We retrospectively analysed the patterns on MRI and MRA, as well as all other available data.
Results
Median age at diagnosis was 7 months (IQR: 6–8) with arterial ischaemic stroke in the middle cerebral artery territory. All of the children experienced severe stroke recurrence within a median time of 11 months (IQR: 10–12), and all showed extraneurological symptoms. The anterior cerebral circulation was involved in all cases and the posterior circulation was involved in six. Two children died and all of the other children suffered permanent neurological deficits.
Conclusions
The presence of extraneurological signs in cases of early-onset moyamoya syndrome is suggestive of a newly described systemic vasculopathy with predominantly cerebrovascular expression. Given its rapid progression marked by severe recurrent strokes and poor clinical outcome, early diagnosis could help in the decision to institute aggressive therapy.
Similar content being viewed by others
Abbreviations
- ACA:
-
Cerebral anterior artery
- MCA:
-
Middle cerebral artery
- PCA:
-
Posterior cerebral artery
- ICA:
-
Internal carotid artery
- DSA:
-
Digital subtraction angiography
- MMS:
-
Moyamoya syndrome
- MMD:
-
Moyamoya disease
- MRA:
-
Magnetic resonance angiography
- mRS:
-
Modified Rankin Scale
References
Fukui M (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (’moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99:S238–S240
Fukui M, Kono S, Sueishi K, Ikezaki K (2000) Moyamoya disease. Neuropathol Off J Jpn Soc Neuropathol 20:S61–S64
Kataoka H, Miyamoto S, Nagata I, Hatano T, Kano H, Hashimoto N (1999) Moyamoya disease showing atypical angiographic findings—two case reports. Neurol Med Chir (Tokyo) 39:294–298
Guey S, Tournier-Lasserve E, Hervé D, Kossorotoff M (2015) Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet 8:49–68
Horn P, Pfister S, Bueltmann E, Vajkoczy P, Schmiedek P (2004) Moyamoya-like vasculopathy (moyamoya syndrome) in children. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 20:382–391
Sasaki T, Nogawa S, Amano T (2006) Co-morbidity of moyamoya disease with Graves’ disease. report of three cases and a review of the literature. Intern Med Tokyo Jpn 45:649–653
Tokimura H, Tajitsu K, Takashima H, Hirayama T, Tsuchiya M, Takayama K et al (2010) Familial moyamoya disease associated with Graves’ disease in a mother and daughter. Two case reports. Neurol Med Chir (Tokyo) 50:668–674
Houkin K, Yoshimoto T, Kuroda S, Ishikawa T, Takahashi A, Abe H (1996) Angiographic analysis of moyamoya disease--how does moyamoya disease progress? Neurol Med Chir (Tokyo) 36:783–787, discussion 788
Amlie-Lefond C, Zaidat OO, Lew SM (2011) Moyamoya disease in early infancy: case report and literature review. Pediatr Neurol 44:299–302
Harrison JK, McArthur KS, Quinn TJ (2013) Assessment scales in stroke: clinimetric and clinical considerations. Clin Interv Aging 8:201–211
Nassaf M, Draiss G, Rada N, Bourrous M, Bouskraoui M (2012) Moyamoya disease in children: a case report. Arch Pédiatrie Organe Off Sociéte Fr Pédiatrie 19:493–496
Ahmed R, Ahsan H (1997) Imaging of Moya Moya disease. JPMA J Pak Med Assoc 47:181–185
Manceau E, Giroud M, Dumas R (1997) Moyamoya disease in children. A review of the clinical and radiological features and current treatment. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 13:595–600
Funaki T, Takahashi JC, Takagi Y, Yoshida K, Araki Y, Kikuchi T et al (2013) Impact of posterior cerebral artery involvement on long-term clinical and social outcome of pediatric moyamoya disease. J Neurosurg Pediatr 12:626–632
Kuroda S, Ishikawa T, Houkin K, Iwasaki Y (2002) Clinical significance of posterior cerebral artery stenosis/occlusion in moyamoya disease. No Shinkei Geka 30:1295–1300
Miyamoto S, Kikuchi H, Karasawa J, Nagata I, Ikota T, Takeuchi S (1984) Study of the posterior circulation in moyamoya disease. Clinical and neuroradiological evaluation. J Neurosurg 61:1032–1037
Tamogami R, Oi S, Nonaka Y, Miwa T, Abe T (2010) Clinical prognosis and therapeutic aspects in management of pediatric moyamoya disease. Nihon Rinsho Jpn J Clin Med 68:45–52
Currie S, Raghavan A, Batty R, Connolly DJA, Griffiths PD (2011) Childhood moyamoya disease and moyamoya syndrome: a pictorial review. Pediatr Neurol 44:401–413
Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A et al (2011) A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 56:34–40
Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T et al (2011) Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6, e22542
Wu Z, Jiang H, Zhang L, Xu X, Zhang X, Kang Z et al (2012) Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS One 7, e48179
Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I et al (2012) Homozygous c.14576G > A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 78:803–810
Mineharu Y, Takagi Y, Takahashi JC, Hashikata H, Liu W, Hitomi T et al (2013) Rapid progression of unilateral moyamoya disease in a patient with a family history and an RNF213 risk variant. Cerebrovasc Dis Basel Switz 36:155–157
Morito D, Nishikawa K, Hoseki J, Kitamura A, Kotani Y, Kiso K et al (2014) Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state. Sci Rep 4:4442
Buerki S, Steinlin M (2013) Coexistent childhood renovascular and cerebrovascular disease. Dev Med Child Neurol 55:297–298
Willsher A, Roebuck DJ, Ng J, Ganesan V (2013) How commonly do children with complex cerebral arteriopathy have renovascular disease? Dev Med Child Neurol 55:335–340
Richard MA, Grob JJ, Durand JM, Noë C, Basseres N, Bonerandi JJ (1994) Sneddon syndrome. Ann Dermatol Vénéréologie 121:331–337
Scott IA, Boyle RS (1986) Sneddon’s syndrome. Aust N Z J Med 16:799–802
Legierse CM, Canninga-Van Dijk MR, Bruijnzeel-Koomen CAFM, Kuck-Koot VCM (2008) Sneddon syndrome and the diagnostic value of skin biopsies - three young patients with intracerebral lesions and livedo racemosa. Eur J Dermatol EJD 18:322–328
Zaccariotti VA, Martins LF, da Costa V, Silva NA, da Casas AA, de Melo-Souza SE (1995) Sneddon syndrome. Report of 3 cases. Arq Neuropsiquiatr 53:82–87
Maamar M, Rahmani M, Aidi S, Benabdeljlil M, El Hassani My R, Jiddane M et al (2007) Sneddon’s syndrome: 15 cases with cerebral angiography. Rev Neurol (Paris) 163:809–816
Provenzale JM, Barboriak DP, Allen NB, Ortel TL (1998) Antiphospholipid antibodies: findings at arteriography. AJNR Am J Neuroradiol 19:611–616
Pomper MG, Miller TJ, Stone JH, Tidmore WC, Hellmann DB (1999) CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. AJNR Am J Neuroradiol 20:75–85
Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV et al (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370:911–920
Kotagal S, Peterson PL, Martens ME, Lee CP, Nigro M, Archer CR (1988) Impaired NADH-CoQ reductase activity in a child with moyamoya syndrome. Pediatr Neurol 4:241–244
Cullu N, Karakas E, Karakas O, Deveer M, Calik M, Boyaci FN (2013) Childhood moyamoya disease accompanying Leigh syndrome. JPMA J Pak Med Assoc 63:1538–1540
Marcinkevicius E, Liutkus D, Gvazdaitis A (2006) Experience of treatment of moyamoya disease at the Clinic of Neurosurgery of Kaunas University of Medicine. Med Kaunas Lith 42:130–136
Kim S-K, Seol HJ, Cho B-K, Hwang Y-S, Lee DS, Wang K-C (2004) Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery 54:840–844, discussion 844–846
Imaizumi T, Hayashi K, Saito K, Osawa M, Fukuyama Y (1998) Long-term outcomes of pediatric moyamoya disease monitored to adulthood. Pediatr Neurol 18:321–325
Jackson EM, Lin N, Manjila S, Scott RM, Smith ER (2014) Pial synangiosis in patients with moyamoya younger than 2 years of age. J Neurosurg Pediatr 13:420–425
Acknowledgments
The scientific guarantor of this publication is Catherine Adamsbaum. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. No complex statistical methods were necessary for this paper. Institutional Review Board approval was not required in accordance with French and European ethical guidelines (standard care). Written informed consent was not required for this study because this was a non-interventional retrospective study. Methodology: retrospective, observational, multicentre study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Law-ye, B., Saliou, G., Toulgoat, F. et al. Early-onset stroke with moyamoya-like syndrome and extraneurological signs: a first reported paediatric series. Eur Radiol 26, 2853–2862 (2016). https://doi.org/10.1007/s00330-015-4119-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-015-4119-z